APBN New Site

APBN Developing Site

Cure Brain Cancer Foundation Offers Support to Promising Mid-Career Researchers This World Cancer Day

The support will help fund research to improve patient outcomes for individuals with brain cancer.

Cure Brain Cancer Foundation is inviting applications for its first Mid-Career Fellowship to mark World Cancer Day on Friday, February 4.

The Fellowship, worth up to $420,000, will provide three years’ support across salary and project funding, allowing researchers to continue their work to improve outcomes for people affected by brain cancer.

Cure Brain Cancer Foundation CEO Lance Kawaguchi said the funding will provide much-needed stability to future leaders working in the field.

“It’s estimated only 3.5 per cent of mid-career researchers will continue a career in research due to a lack of stability and funding opportunities,” Mr Kawaguchi said.

“This creates a bottleneck situation where we’re losing talented brain cancer researchers and important knowledge and skills from the field.

“Brain cancer is one of the hardest cancers to treat. Tragically, it kills more children in Australia than any other disease and more people under 40 than any other cancer. Research is absolutely vital to help us increase survival and ultimately find a cure for this devastating disease.

“This multi-year Fellowship supports promising mid-career researchers who are at the greatest risk of leaving the research field. It will allow them to progress their work in finding innovative and effective treatments for people affected by brain cancer.”

Applications for the Fellowship will open on Friday, February 4. Mid-career researchers across Australia and New Zealand are invited to apply.

Cure Brain Cancer Foundation is Australia’s leading brain cancer organisation for research, advocacy, and awareness. The Fellowship is part of the Foundation’s Brilliant Minds programme, which encourages early-career researchers to move into brain cancer and supports the growth of experienced researchers in the field.

Since 2013, the Foundation has invested more than $21 million into priority-driven research. In 2021, it awarded an Early Career Fellowship worth $345,000 to Dr. Yolanda Sanguino at the Children’s Cancer Institute. Dr. Sanguino’s Fellowship will support her research into novel therapies for the deadliest childhood brain cancer, diffuse intrinsic pontine glioma. [APBN]

Source: Cure Brain Cancer Foundation